Hormone producing gynecological tumors: pathologic entities and clinical significance

References

• Gadducci A, Cosio S, Carpi A, et al. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother. 2004 Jan;58(1):24–38.
   PubMed Web of Science ®Google Scholar
• Ueda Y, Enomoto T, Kimura T, et al. Serum biomarkers for early detection of gynecologic cancers. Cancers (Basel). 2010 Jun 14;2(2):1312–1327.
   PubMedGoogle Scholar
• Dasari S, Wudayagiri R, Valluru L. Cervical cancer: biomarkers for diagnosis and treatment. Clin Chim Acta. 2015 May 20;445:7–11.
   PubMed Web of Science ®Google Scholar
• De Mees C, Laes JF, Bakker J, et al. Alpha-fetoprotein controls female fertility and prenatal development of the gonadotropin-releasing hormone pathway through an antiestrogenic action. Mol Cell Biol. 2006 Mar;26(5):2012–2018.
   PubMed Web of Science ®Google Scholar
• Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol. 1994 Nov;18(11):1102–1116.
   PubMed Web of Science ®Google Scholar
• Ramos P, Karnezis AN, Craig DW, et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet. 2014 May;46(5):427–429.
   PubMed Web of Science ®Google Scholar
• Witkowski L, Carrot-Zhang J, Albrecht S, et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet. 2014 May;46(5):438–443.
   PubMed Web of Science ®Google Scholar
• Berchuck A, Witkowski L, Hasselblatt M, et al. Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type. Gynecol Oncol Rep. 2015 Apr;12:20–22.
   PubMed Web of Science ®Google Scholar
• Hoekman K, Tjandra YI, Papapoulos SE. The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein. Cancer. 1991 Aug 01;68(3):642–647.
   PubMed Web of Science ®Google Scholar
• Fujino T, Watanabe T, Yamaguchi K, et al. The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein. Cancer. 1992 Dec 15;70(12):2845–2850.
   PubMed Web of Science ®Google Scholar
• Matias-Guiu X, Prat J, Young RH, et al. Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study. Cancer. 1994 Apr 1;73(7):1878–1881.
   PubMed Web of Science ®Google Scholar
• Eichhorn JH, Young RH, Scully RE. Primary ovarian small cell carcinoma of pulmonary type. A clinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases. Am J Surg Pathol. 1992 Oct;16(10):926–938.
   PubMed Web of Science ®Google Scholar
• Atienza-Amores M, Guerini-Rocco E, Soslow RA, et al. Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol. 2014 Aug;134(2):410–418.
   PubMed Web of Science ®Google Scholar
• Brown H, Lane M. Cushing’s and malignant carcinoid syndromes from ovarian neoplasm. Arch Intern Med. 1965 Apr;115:490–494.
   PubMedGoogle Scholar
• Lindboe CF. Large cell neuroendocrine carcinoma of the ovary. APMIS. 2007 Feb;115(2):169–176.
   PubMed Web of Science ®Google Scholar
• Ki EY, Park JS, Lee KH, et al. Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature. World J Surg Oncol. 2014;12:314.
   PubMed Web of Science ®Google Scholar
• Ohira S, Itoh K, Shiozawa T, et al. Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia. Int J Gynecol Pathol. 2004 Oct;23(4):393–397.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhong Y, Sun L, et al. Clinical and pathological features of hepatoid carcinoma of the ovary. World J Surg Oncol. 2013;11:29.
   PubMed Web of Science ®Google Scholar
• Randolph LK, Hopkins MK, Hopkins MP, et al. Hepatoid carcinoma of the ovary: a case report and review of the literature. Gynecol Oncol Rep. 2015 Aug;13:64–67.
   PubMed Web of Science ®Google Scholar
• Sung JH, Kim TH, Park HG, et al. Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein. Obstet Gynecol Sci. 2013 Jan;56(1):41–44.
   PubMedGoogle Scholar
• Kamal NM, Khan U, Mirza S, et al. Ovarian dysgerminoma with normal serum tumour markers presenting in a child with precocious puberty. J Cancer Res Ther. 2015 Jul-Sep;11(3):661.
   PubMed Web of Science ®Google Scholar
• Von Eyben FE. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors. Clin Biochem. 2001 Sep;34(6):441–454.
   PubMed Web of Science ®Google Scholar
• Pressley RH, Muntz HG, Falkenberry S, et al. Serum lactic dehydrogenase as a tumor marker in dysgerminoma. Gynecol Oncol. 1992 Mar;44(3):281–283.
   PubMed Web of Science ®Google Scholar
• Kemp B, Hauptmann S, Schroder W, et al. Dysgerminoma of the ovary in a patient with triple-X syndrome. Int J Gynaecol Obstet. 1995 Jul;50(1):51–53.
   PubMed Web of Science ®Google Scholar
• Nogales FF, Bergeron C, Carvia RE, et al. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am J Surg Pathol. 1996 Sep;20(9):1056–1066.
   PubMed Web of Science ®Google Scholar
• Gevers EF, Meredith S, Shah P, et al. Cushing syndrome in a child due to pro-opiomelanocortin (POMC) secretion from a yolk sac tumor. Eur J Endocrinol. 2017 Feb;176(2):K1–K7.
   PubMed Web of Science ®Google Scholar
• Talerman A, Haije WG, Baggerman L. Serum alphafetoprotein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovary. Cancer. 1978 Jan;41(1):272–278.
   PubMed Web of Science ®Google Scholar
• De La Motte Rouge T, Duvillard P, Rey A, et al. Prognostic significance of serum alphafoetoprotein early decline in ovarian yolk sac tumor. Ann Oncol. 2014;25:313–314.
   Google Scholar
• Nogales FF, Dulcey I, Preda O. Germ cell tumors of the ovary: an update. Arch Pathol Lab Med. 2014 Mar;138(3):351–362.
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Norris HJ. Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer. 1976 Dec;38(6):2420–2433.
   PubMed Web of Science ®Google Scholar
• Ueda G, Abe Y, Yoshida M, et al. Embryonal carcinoma of the ovary: a six-year survival. Int J Gynaecol Obstet. 1990 Mar;31(3):287–292.
   PubMed Web of Science ®Google Scholar
• Jondle DM, Shahin MS, Sorosky J, et al. Ovarian mixed germ cell tumor with predominance of polyembryoma: a case report with literature review. Int J Gynecol Pathol. 2002 Jan;21(1):78–81.
   PubMed Web of Science ®Google Scholar
• Takeda A, Ishizuka T, Goto T, et al. Polyembryoma of ovary producing alpha-fetoprotein and HCG: immunoperoxidase and electron microscopic study. Cancer. 1982 May 1;49(9):1878–1889.
   PubMed Web of Science ®Google Scholar
• Takemori M, Nishimura R, Yamasaki M, et al. Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma. Gynecol Oncol. 1998 Jun;69(3):260–263.
   PubMed Web of Science ®Google Scholar
• Shaaban AM, Rezvani M, Elsayes KM, et al. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. Radiographics. 2014 May-Jun;34(3):777–801.
   PubMed Web of Science ®Google Scholar
• Nishida M, Kawano Y, Yuge A, et al. Three cases of immature teratoma diagnosed after laparoscopic operation. Clin Med Insights Case Rep. 2014;7:91–94.
   PubMedGoogle Scholar
• Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976 May;37(5):2359–2372.
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Takei Y, Saga Y, et al. Immature ovarian teratoma with hyponatremia and low serum vasopressin level. J Obstet Gynaecol Res. 2016 Oct;42(10):1400–1404.
   PubMed Web of Science ®Google Scholar
• Perrone T, Steeper TA, Dehner LP. Alpha-fetoprotein localization in pure ovarian teratoma. An immunohistochemical study of 12 cases. Am J Clin Pathol. 1987 Dec;88(6):713–717.
   PubMed Web of Science ®Google Scholar
• Bonazzi C, Peccatori F, Colombo N, et al. Pure ovarian immature teratoma, a unique and curable disease: 10 years’ experience of 32 prospectively treated patients. Obstet Gynecol. 1994 Oct;84(4):598–604.
   PubMed Web of Science ®Google Scholar
• Palmer PE, Bogojavlensky S, Bhan AK, et al. Prolactinoma in wall of ovarian dermoid cyst with hyperprolactinemia. Obstet Gynecol. 1990 Mar;75(3 Pt 2):540–543.
   PubMed Web of Science ®Google Scholar
• Kallenberg GA, Pesce CM, Norman B, et al. Ectopic hyperprolactinemia resulting from an ovarian teratoma. Jama. 1990 May 9;263(18):2472–2474.
   PubMed Web of Science ®Google Scholar
• Yoo SC, Chang KH, Lyu MO, et al. Clinical characteristics of struma ovarii. J Gynecol Oncol. 2008 Jun;19(2):135–138.
   PubMedGoogle Scholar
• Wei S, Baloch ZW, LiVolsi VA. Pathology of struma ovarii: a report of 96 cases. Endocr Pathol. 2015 Dec; 26(4):342–348.
   PubMed Web of Science ®Google Scholar
• Ayhan A, Yanik F, Tuncer R, et al. Struma ovarii. Int J Gynaecol Obstet. 1993 Aug;42(2):143–146.
   PubMed Web of Science ®Google Scholar
• Marcus CC, Marcus SL. Struma ovarii. A report of 7 cases and a review of the subject. Am J Obstet Gynecol. 1961 Apr;81:752–762.
   PubMed Web of Science ®Google Scholar
• Robboy SJ, Scully RE. Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer. 1980 Nov 01;46(9):2019–2034.
   PubMed Web of Science ®Google Scholar
• Motoyama T, Katayama Y, Watanabe H, et al. Functioning ovarian carcinoids induce severe constipation. Cancer. 1992 Jul 15;70(2):513–518.
   PubMed Web of Science ®Google Scholar
• Sporrong B, Falkmer S, Robboy SJ, et al. Neurohormonal peptides in ovarian carcinoids: an immunohistochemical study of 81 primary carcinoids and of intraovarian metastases from six mid-gut carcinoids. Cancer. 1982 Jan 1;49(1):68–74.
   PubMedGoogle Scholar
• Robboy SJ, Norris HJ, Scully RE. Insular carcinoid primary in the ovary. A clinicopathologic analysis of 48 cases. Cancer. 1975 Aug;36(2):404–418.
   PubMed Web of Science ®Google Scholar
• Diaz-Montes TP, Rosenthal LE, Bristow RE, et al. Primary insular carcinoid of the ovary. Gynecol Oncol. 2006 Apr;101(1):175–178.
   PubMed Web of Science ®Google Scholar
• Agarwal C, Goel S, Stern E, et al. Carcinoid heart disease without liver involvement caused by a primary ovarian carcinoid tumour. Heart Lung Circ. 2015 Jul;24(7):e97–e100.
   PubMed Web of Science ®Google Scholar
• Hood IC, Jones BA, Watts JC. Mucinous carcinoid tumor of the appendix presenting as bilateral ovarian tumors. Arch Pathol Lab Med. 1986 Apr;110(4):336–340.
   PubMed Web of Science ®Google Scholar
• Wolpert HR, Fuller AF, Bell DA. Primary mucinous carcinoid tumor of the ovary. A case report. Int J Gynecol Pathol. 1989;8(2):156–162.
   PubMed Web of Science ®Google Scholar
• Shigeta H, Taga M, Kurogi K, et al. Ovarian strumal carcinoid with severe constipation: immunohistochemical and mRNA analyses of peptide YY. Hum Pathol. 1999 Feb;30(2):242–246.
   PubMed Web of Science ®Google Scholar
• Muller KE, Tafe LJ, Gonzalez JL, et al. Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature. Int J Gynecol Pathol. 2015 Jan;34(1):30–35.
   PubMed Web of Science ®Google Scholar
• Kottarathil VD, Antony MA, Nair IR, et al. Recent advances in granulosa cell tumor ovary: a review. Indian J Surg Oncol. 2013 Mar;4(1):37–47.
   PubMedGoogle Scholar
• Fox H, Agrawal K, Langley FA. A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer. 1975 Jan;35(1):231–241.
   PubMed Web of Science ®Google Scholar
• Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol. 1981 Jun;11(3):261–274.
   PubMed Web of Science ®Google Scholar
• Ohel G, Kaneti H, Schenker JG. Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol. 1983 Apr;15(2):278–286.
   PubMed Web of Science ®Google Scholar
• Rey RA, Lhomme C, Marcillac I, et al. Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol. 1996 Mar;174(3):958–965.
   PubMed Web of Science ®Google Scholar
• Lappohn RE, Burger HG, Bouma J, et al. Inhibin as a marker for granulosa-cell tumors. N Engl J Med. 1989 Sep 21;321(12):790–793.
   PubMed Web of Science ®Google Scholar
• La Marca A, Volpe A. The Anti-Mullerian hormone and ovarian cancer. Hum Reprod Update. 2007 May-Jun;13(3):265–273.
   PubMed Web of Science ®Google Scholar
• Caron P, Cogne M, Rumeau JL, et al. Androgenic granulosa cell tumor of the ovary: in vivo hormonal studies. J Endocrinol Invest. 1993 Jul-Aug;16(7):545–548.
   PubMed Web of Science ®Google Scholar
• Jarboe EA, Hirschowitz SL, Geiersbach KB, et al. Juvenile granulosa cell tumors: immunoreactivity for CD99 and Fli-1 and EWSR1 translocation status: a study of 11 cases. Int J Gynecol Pathol. 2014 Jan;33(1):11–15.
   PubMed Web of Science ®Google Scholar
• Nishida M, Jimi S, Haji M, et al. Juvenile granulosa cell tumor in association with a high serum inhibin level. Gynecol Oncol. 1991 Jan;40(1):90–94.
   PubMed Web of Science ®Google Scholar
• Podfigurna-Stopa A, Czyzyk A, Katulski K, et al. Recurrent endometrial hyperplasia as a presentation of estrogen-secreting thecoma - case report and minireview of the literature. Gynecol Endocrinol. 2016;32(3):184–187.
   PubMed Web of Science ®Google Scholar
• Aboud E. A review of granulosa cell tumours and thecomas of the ovary. Arch Gynecol Obstet. 1997;259(4):161–165.
   PubMed Web of Science ®Google Scholar
• Gaffney EF, Majmudar B, Hewan-Lowe K. Ultrastructure and immunohistochemical localization of estradiol in three thecomas. Hum Pathol. 1984 Feb;15(2):153–160.
   PubMed Web of Science ®Google Scholar
• Givens JR, Andersen RN, Wiser WL, et al. A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease. J Clin Endocrinol Metab. 1975 Nov;41(5):845–853
   PubMed Web of Science ®Google Scholar
• Siekierska-Hellmann M, Sworczak K, Babinska A, et al. Ovarian thecoma with androgenic manifestations in a postmenopausal woman. Gynecol Endocrinol. 2006 Jul;22(7):405–408.
   PubMed Web of Science ®Google Scholar
• Lee MH, Moon YJ, Ha CW, et al. Ovarian thecoma with virilizing manifestations. Yonsei Med J. 2009 Feb 28;50(1):169–173.
   PubMed Web of Science ®Google Scholar
• Oliva E, Alvarez T, Young RH. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2005 Feb;29(2):143–156.
   PubMed Web of Science ®Google Scholar
• Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013 Jan;62(1):71–88.
   PubMed Web of Science ®Google Scholar
• Korzets A, Nouriel H, Steiner Z, et al. Resistant hypertension associated with a renin-producing ovarian Sertoli cell tumor. Am J Clin Pathol. 1986 Feb;85(2):242–247.
   PubMed Web of Science ®Google Scholar
• Tracy SL, Askin FB, Reddick RL, et al. Progesterone secreting Sertoli cell tumor of the ovary. Gynecol Oncol. 1985 Sep;22(1):85–96.
   PubMed Web of Science ®Google Scholar
• En Do E, Samuels LT. Aldosteronism and precocious puberty due to an ovarian androblastoma. J Clin Endocrinol Metab. 1963;23:358–367.
   Web of Science ®Google Scholar
• Young RH, Scully RE. Ovarian Sertoli cell tumors: a report of 10 cases. Int J Gynecol Pathol. 1984;2(4):349–363.
   PubMed Web of Science ®Google Scholar
• Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985 Aug;9(8):543–569.
   PubMed Web of Science ®Google Scholar
• Mooney EE, Nogales FF, Bergeron C, et al. Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology. 2002 Aug;41(2):110–117.
   PubMed Web of Science ®Google Scholar
• Grove A, Vestergaard V. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature. Ann Diagn Pathol. 2006 Oct;10(5):288–293.
   PubMedGoogle Scholar
• Prat J, Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer. 1982 Dec 1;50(11):2465–2475.
   PubMed Web of Science ®Google Scholar
• Kato N, Kusumi T, Kamataki A, et al. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects. Hum Pathol. 2017 Jan;59:41–47.
   PubMed Web of Science ®Google Scholar
• Gui T, Cao D, Shen K, et al. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecol Oncol. 2012 Nov;127(2):384–389.
   PubMed Web of Science ®Google Scholar
• Young RH, Perez-Atayde AR, Scully RE. Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein. Am J Surg Pathol. 1984 Sep;8(9):709–718.
   PubMed Web of Science ®Google Scholar
• Gagnon S, Tetu B, Silva EG, et al. Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases. Mod Pathol. 1989 Jan;2(1):63–67.
   PubMed Web of Science ®Google Scholar
• Motoyama I, Watanabe H, Gotoh A, et al. Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein. Cancer. 1989 May 15;63(10):2047–2053.
   PubMed Web of Science ®Google Scholar
• Takeda A, Watanabe K, Hayashi S, et al. Gynandroblastoma with a juvenile granulosa cell component in an adolescent: case report and literature review. J Pediatr Adolesc Gynecol. 2017 Apr;30(2):251–255.
   PubMed Web of Science ®Google Scholar
• Chan R, Tucker M, Russell P. Ovarian gynandroblastoma with juvenile granulosa cell component and raised alpha fetoprotein. Pathology. 2005 Aug;37(4):312–315.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ohmi K, Tsunematu R, et al. Gynandroblastoma of the ovary having a typical morphological appearance: a case study. Jpn J Clin Oncol. 1991 Feb;21(1):62–68.
   PubMed Web of Science ®Google Scholar
• Ravishankar S, Mangray S, Kurkchubasche A, et al. Unusual Sertoli cell tumor associated with sex cord tumor with annular tubules in Peutz-Jeghers syndrome: report of a case and review of the literature on ovarian tumors in Peutz-Jeghers syndrome. Int J Surg Pathol. 2016 May;24(3):269–273.
   PubMed Web of Science ®Google Scholar
• Young RH, Welch WR, Dickersin GR, et al. Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer. 1982 Oct 1;50(7):1384–1402.
   PubMed Web of Science ®Google Scholar
• Shen K, Wu PC, Lang JH, et al. Ovarian sex cord tumor with annular tubules: a report of six cases. Gynecol Oncol. 1993 Feb;48(2):180–184.
   PubMed Web of Science ®Google Scholar
• Gustafson ML, Lee MM, Scully RE, et al. Mullerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med. 1992 Feb 13;326(7):466–471.
   PubMed Web of Science ®Google Scholar
• Hayes MC, Scully RE. Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases. Am J Surg Pathol. 1987 Nov;11(11):835–845.
   PubMed Web of Science ®Google Scholar
• Tai YJ, Chang WC, Kuo KT, et al. Ovarian steroid cell tumor, not otherwise specified, with virilization symptoms. Taiwan J Obstet Gynecol. 2014 Jun;53(2):260–262.
   PubMed Web of Science ®Google Scholar
• Zhang J, Young RH, Arseneau J, et al. Ovarian stromal tumors containing lutein or Leydig cells (luteinized thecomas and stromal Leydig cell tumors)–a clinicopathological analysis of fifty cases. Int J Gynecol Pathol. 1982;1(3):270–285.
   PubMed Web of Science ®Google Scholar
• Sternberg WH, Roth LM. Ovarian stromal tumors containing Leydig cells. I. Stromal-Leydig cell tumor and non-neoplastic transformation of ovarian stroma to Leydig cells. Cancer. 1973 Oct;32(4):940–951.
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Ishihara N, Ohbayashi C, et al. Stromal Leydig cell tumor of the ovary. Case report and literature review. Int J Gynecol Pathol. 1999 Apr;18(2):178–182.
   PubMed Web of Science ®Google Scholar
• Kozan P, Chalasani S, Handelsman DJ, et al. A Leydig cell tumor of the ovary resulting in extreme hyperandrogenism, erythrocytosis, and recurrent pulmonary embolism. J Clin Endocrinol Metab. 2014 Jan;99(1):12–17.
   PubMed Web of Science ®Google Scholar
• Ji M, Lu Y, Guo L, et al. Endometrial carcinoma with yolk sac tumor-like differentiation and elevated serum beta-hCG: a case report and literature review. Onco Targets Ther. 2013;6:1515–1522.
   PubMed Web of Science ®Google Scholar
• Horn LC, Hanel C, Bartholdt E, et al. Serous carcinoma of the endometrium with choriocarcinomatous differentiation: a case report and review of the literature indicate the existence of 2 prognostically relevant tumor types. Int J Gynecol Pathol. 2006 Jul;25(3):247–251.
   PubMed Web of Science ®Google Scholar
• Pesce C, Merino MJ, Chambers JT, et al. Endometrial carcinoma with trophoblastic differentiation. An aggressive form of uterine cancer. Cancer. 1991 Oct 15;68(8):1799–1802.
   PubMed Web of Science ®Google Scholar
• Yamada T, Mori H, Kanemura M, et al. Endometrial carcinoma with choriocarcinomatous differentiation: a case report and review of the literature. Gynecol Oncol. 2009 May;113(2):291–294.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang Y, Teng F, et al. Pure nongestational uterine choriocarcinoma in a postmenopausal Chinese woman confirmed with short tandem repeat analysis. Am J Obstet Gynecol. 2014 Jul;211(1):e1–e3.
   PubMed Web of Science ®Google Scholar
• Jiao LZ, Xiang Y, Feng FZ, et al. Clinical analysis of 21 cases of nongestational ovarian choriocarcinoma. Int J Gynecol Cancer. 2010 Feb;20(2):299–302.
   PubMed Web of Science ®Google Scholar
• Park SH, Park A, Kim JY, et al. A case of non-gestational choriocarcinoma arising in the ovary of a postmenopausal woman. J Gynecol Oncol. 2009 Sep;20(3):192–194.
   PubMedGoogle Scholar
• Zhao J, Xiang Y, Wan XR, et al. Molecular genetic analyses of choriocarcinoma. Placenta. 2009 Sep;30(9):816–820.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Chun KY, Kim YW, et al. Pure nongestational choriocarcinoma of the ovary: a case report. World J Surg Oncol. 2013;11:7.
   PubMed Web of Science ®Google Scholar
• Rawish KR, Buza N, Zheng W, et al. Endometrial carcinoma with trophoblastic components: clinicopathologic analysis of a rare entity. Int J Gynecol Pathol. 2017 Jun 02. DOI:10.1097/PGP.0000000000000402.
   Google Scholar
• van Hoeven KH, Hudock JA, Woodruff JM, et al. Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol. 1995 Jan;14(1):21–29.
   PubMed Web of Science ®Google Scholar
• Huntsman DG, Clement PB, Gilks CB, et al. Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases. Am J Surg Pathol. 1994 Apr;18(4):364–375.
   PubMed Web of Science ®Google Scholar
• Tsujioka H, Eguchi F, Emoto M, et al. Small-cell carcinoma of the endometrium: an immunohistochemical and ultrastructural analysis. J Obstet Gynaecol Res. 1997 Feb;23(1):9–16.
   PubMedGoogle Scholar
• Katahira A, Akahira J, Niikura H, et al. Small cell carcinoma of the endometrium: report of three cases and literature review. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):1018–1023.
   PubMed Web of Science ®Google Scholar
• Pocrnich CE, Ramalingam P, Euscher ED, et al. Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2016 May;40(5):577–586.
   PubMed Web of Science ®Google Scholar
• Albores-Saavedra J, Martinez-Benitez B, Luevano E. Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol. 2008 Jul;27(3):333–339.
   PubMed Web of Science ®Google Scholar
• Wu QY, Wan XY, Xie X, et al. Endometrial hepatoid adenocarcinoma: a rare cause of elevated serum alpha-fetoprotein. J Obstet Gynaecol Res. 2014 Mar;40(3):873–877.
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Kitazawa S, Hamanishi S, et al. A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman. Int J Gynecol Cancer. 2006 May-Jun;16(3):1442–1445.
   PubMed Web of Science ®Google Scholar
• Spatz A, Bouron D, Pautier P, et al. Primary yolk sac tumor of the endometrium: a case report and review of the literature. Gynecol Oncol. 1998 Aug;70(2):285–288.
   PubMed Web of Science ®Google Scholar
• Rossi R, Stacchiotti D, Bernardini MG, et al. Primary yolk sac tumor of the endometrium: a case report and review of the literature. Am J Obstet Gynecol. 2011 Apr;204(4):e3–e4.
   PubMed Web of Science ®Google Scholar
• Le Bret T, Tranbaloc P, Benbunan JL, et al. [Endometrial choriocarcinoma in peri-menopausal women]. J Gynecol Obstet Biol Reprod (Paris). 2005 Feb;34(1 Pt 1):85–89.
   PubMedGoogle Scholar
• Clement PB, Young RH. Atlas of gynecologic surgical pathology. 3rd ed. London: Elsevier; 2014.
   Google Scholar
• Bagshawe KD. Choriocarcinoma. A model for tumour markers. Acta Oncol. 1992;31(1):99–106.
   PubMed Web of Science ®Google Scholar
• Braunstein GD, Vaitukaitis JL, Carbone PP, et al. Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med. 1973 Jan;78(1):39–45.
   PubMed Web of Science ®Google Scholar
• Jia N, Chen Y, Tao X, et al. A gestational choriocarcinoma of the ovary diagnosed by DNA polymorphic analysis: a case report and systematic review of the literature. J Ovarian Res. 2017 Jul 20;10(1):46.
   PubMedGoogle Scholar
• Luiza JW, Taylor SE, Gao FF, et al. Placental site trophoblastic tumor: immunohistochemistry algorithm key to diagnosis and review of literature. Gynecol Oncol Case Rep. 2014 Jan;7:13–15.
   PubMedGoogle Scholar
• Baergen RN, Rutgers JL, Young RH, et al. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol. 2006 Mar;100(3):511–520.
   PubMed Web of Science ®Google Scholar
• Chang YL, Chang TC, Hsueh S, et al. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999 May;73(2):216–222.
   PubMed Web of Science ®Google Scholar
• Cole LA, Khanlian SA, Muller CY. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results. J Reprod Med. 2008 Jul;53(7):457–464.
   PubMed Web of Science ®Google Scholar
• Piura B. Placental site trophoblastic tumor–a challenging rare entity. Eur J Gynaecol Oncol. 2006;27(6):545–551.
   PubMed Web of Science ®Google Scholar
• Shih IM, Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol. 1998 Nov;22(11):1393–1403.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lu W, Lu B. Epithelioid trophoblastic tumor: an outcome-based literature review of 78 reported cases. Int J Gynecol Cancer. 2013 Sep;23(7):1334–1338.
   PubMed Web of Science ®Google Scholar
• Davis MR, Howitt BE, Quade BJ, et al. Epithelioid trophoblastic tumor: a single institution case series at the New England Trophoblastic Disease Center. Gynecol Oncol. 2015 Jun;137(3):456–461.
   PubMed Web of Science ®Google Scholar
• Andersson S, Mints M, Gyllensten U, et al. Uneven distribution of human papillomavirus 16 in cervical carcinoma in situ and squamous cell carcinoma in older females: a retrospective database study. Oncol Lett. 2014 Oct;8(4):1528–1532.
   PubMed Web of Science ®Google Scholar
• Duk JM, Groenier KH, De Bruijn HW, et al. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol. 1996 Jan;14(1):111–118.
   PubMed Web of Science ®Google Scholar
• Takeda M, Sakuragi N, Okamoto K, et al. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix. Acta Obstet Gynecol Scand. 2002 May;81(5):451–457.
   PubMed Web of Science ®Google Scholar
• De Bruijn HW, Duk JM, Van Der Zee AG, et al. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumour Biol. 1998;19(6):505–516.
   PubMedGoogle Scholar
• Strauss HG, Laban C, Lautenschlager C, et al. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix. Eur J Cancer. 2002 Oct;38(15):1987–1991.
   PubMed Web of Science ®Google Scholar
• Oh J, Lee HJ, Lee TS, et al. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation. Obstet Gynecol Sci. 2016 Jul;59(4):269–278.
   PubMedGoogle Scholar
• Salvatici M, Achilarre MT, Sandri MT, et al. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: role in the early diagnosis of recurrence. Gynecol Oncol. 2016 Jul;142(1):115–119.
   PubMed Web of Science ®Google Scholar
• Tsai SC, Kao CH, Wang SJ. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen. Neoplasma. 1996;43(1):27–29.
   PubMed Web of Science ®Google Scholar
• Piao X, Kong TW, Chang SJ, et al. Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases. Gynecol Oncol. 2015 Jul;138(1):89–93.
   PubMed Web of Science ®Google Scholar
• Kyo S, Kanaya T, Takakura M, et al. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6. Gynecol Oncol. 2000 Sep;78(3 Pt 1):383–387.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Wachi T, Omi H, et al. Granulocyte colony-stimulating factor-producing small-cell carcinoma of the uterine cervix: report of a case. Diagn Cytopathol. 2000 Oct;23(4):269–274.
   PubMed Web of Science ®Google Scholar
• Nasu K, Inoue C, Takai N, et al. Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor. Obstet Gynecol. 2004 Nov;104(5 Pt 1):1086–1088.
   PubMed Web of Science ®Google Scholar
• Ahn HJ, Park YH, Chang YH, et al. A case of uterine cervical cancer presenting with granulocytosis. Korean J Intern Med. 2005 Sep;20(3):247–250.
   PubMedGoogle Scholar
• Matsumoto Y, Mabuchi S, Muraji M, et al. Squamous cell carcinoma of the uterine cervix producing granulocyte colony-stimulating factor: a report of 4 cases and a review of the literature. Int J Gynecol Cancer. 2010 Apr;20(3):417–421.
   PubMed Web of Science ®Google Scholar
• Mabuchi S, Matsumoto Y, Morii E, et al. The first 2 cases of granulocyte colony-stimulating factor producing adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 2010 Sep;29(5):483–487.
   PubMed Web of Science ®Google Scholar
• Ohkubo Y, Kato S, Kiyohara H, et al. Granulocyte-colony stimulating factor-producing cervical cancers treated with carbon-ion irradiation. J Obstet Gynaecol Res. 2013 May;39(5):1111–1115.
   PubMed Web of Science ®Google Scholar
• Shintaku M, Kariya M, Shime H, et al. Adenocarcinoma of the uterine cervix with choriocarcinomatous and hepatoid differentiation: report of a case. Int J Gynecol Pathol. 2000 Apr;19(2):174–178.
   PubMed Web of Science ®Google Scholar
• Pavelka JC, Bryant DA, Vaccarello L. Adenocarcinoma of the uterine cervix with choriocarcinomatous metastasis. Gynecol Oncol. 2006 May;101(2):346–348.
   PubMed Web of Science ®Google Scholar
• Nikolic B, Curkovic A, Dikic SD, et al. Cervical poorly differentiated adenocarcinoma with dominant choriocarcinomatous pattern–A case report. Vojnosanit Pregl. 2015 Jul;72(7):651–653.
   PubMed Web of Science ®Google Scholar
• Kuji S, Watanabe R, Sato Y, et al. A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases. Gynecol Oncol. 2017 Feb;144(2):384–390.
   PubMed Web of Science ®Google Scholar
• Iemura K, Sonoda T, Hayakawa A, et al. Small cell carcinoma of the uterine cervix showing Cushing’s syndrome caused by ectopic adrenocorticotropin hormone production. Jpn J Clin Oncol. 1991 Aug;21(4):293–298.
   PubMed Web of Science ®Google Scholar
• Ishibashi-Ueda H, Imakita M, Yutani C, et al. Small cell carcinoma of the uterine cervix with syndrome of inappropriate antidiuretic hormone secretion. Mod Pathol. 1996 Apr;9(4):397–400.
   PubMed Web of Science ®Google Scholar
• Lojek MA, Fer MF, Kasselberg AG, et al. Cushing’s syndrome with small cell carcinoma of the uterine cervix. Am J Med. 1980 Jul;69(1):140–144.
   PubMed Web of Science ®Google Scholar
• Stockdale AD, Leader M, Phillips RH, et al. The carcinoid syndrome and multiple hormone secretion associated with a carcinoid tumour of the uterine cervix. Case report. Br J Obstet Gynaecol. 1986 Apr;93(4):397–401.
   PubMedGoogle Scholar
• Gilks CB, Young RH, Gersell DJ, et al. Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol. 1997 Aug;21(8):905–914.
   PubMedGoogle Scholar
• Seckl MJ, Mulholland PJ, Bishop AE, et al. Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med. 1999 Sep 2;341(10):733–736.
   PubMed Web of Science ®Google Scholar
• Young RH, Gersell DJ, Roth LM, et al. Ovarian metastases from cervical carcinomas other than pure adenocarcinomas. A report of 12 cases. Cancer. 1993 Jan 15;71(2):407–418.
   PubMed Web of Science ®Google Scholar
• Papatsimpas G, Samaras I, Theodosiou P, et al. A case of cervical carcinoid and review of the literature. Case Rep Oncol. 2017 May-Aug;10(2):737–742.
   PubMed Web of Science ®Google Scholar
• Koch CA, Azumi N, Furlong MA, et al. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab. 1999 Nov;84(11):4209–4213.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Sato K, Katayama K, et al. Atypical metastatic carcinoid of the uterine cervix and review of the literature. J Obstet Gynaecol Res. 2011 Jun;37(6):636–640.
   PubMed Web of Science ®Google Scholar
• Saltzman AF, Gills JR, LeBlanc DM, et al. Multimodal management of a pediatric cervical yolk sac tumor. Urology. 2015 May;85(5):1186–1189.
   PubMed Web of Science ®Google Scholar
• Copeland LJ, Sneige N, Ordonez NG, et al. Endodermal sinus tumor of the vagina and cervix. Cancer. 1985 Jun 1;55(11):2558–2565.
   PubMed Web of Science ®Google Scholar
• Agarano AR, Alvarez AU, Amora CM, et al. Malignant extragonadal yolk sac tumor of the cervix in a 2-year-old female: case report. SPMC J Health Care Services. 2016;2(1):40–45.
   Google Scholar
• Rajagopal R, Ariffin H, Krishnan S, et al. Pediatric vaginal yolk sac tumor: reappraisal of treatment strategy in a rare tumor at a unique location. J Pediatr Hematol Oncol. 2015 Jul;37(5):391–395.
   PubMed Web of Science ®Google Scholar
• Bing Z, Levine L, Lucci JA, et al. Primary small cell neuroendocrine carcinoma of the vagina: a clinicopathologic study. Arch Pathol Lab Med. 2004 Aug;128(8):857–862.
   PubMed Web of Science ®Google Scholar
• Colleran KM, Burge MR, Crooks LA, et al. Small cell carcinoma of the vagina causing Cushing’s syndrome by ectopic production and secretion of ACTH: a case report. Gynecol Oncol. 1997 Jun;65(3):526–529.
   PubMed Web of Science ®Google Scholar
• Weberpals J, Djordjevic B, Khalifa M, et al. A rare case of ectopic adrenocorticotropic hormone syndrome in small cell carcinoma of the vagina: a case report. J Low Genit Tract Dis. 2008 Apr;12(2):140–145.
   PubMed Web of Science ®Google Scholar
• Bhatt MD, Braga LH, Stein N, et al. Vaginal yolk sac tumor in an infant: a case report and literature review of the last 30 years. J Pediatr Hematol Oncol. 2015 Jul;37(5):e336–e340.
   PubMed Web of Science ®Google Scholar
• Young RH, Scully RE. Endodermal sinus tumor of the vagina: a report of nine cases and review of the literature. Gynecol Oncol. 1984 Jul;18(3):380–392.
   PubMed Web of Science ®Google Scholar